| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.809 | 0.002 | 0.809 | Anesthetic general | 0.725 0.003 CID_9395 | ||
| 0.802 | 0.003 | 0.802 | Acetylcholinesterase inhibitor | 0.2 0.033 CID_9395 | ||
| 0.775 | 0.004 | 0.775 | Cholinergic | 0.149 0.078 CID_9395 | ||
| 0.754 | 0.002 | 0.754 | Aldehyde dehydrogenase inhibitor | 0.396 0.005 CID_9395 | ||
| 0.694 | 0.01 | 0.694 | Thyroid hormone antagonist | 0.337 0.078 CID_9395 | ||
| 0.676 | 0.003 | 0.676 | Butyrylcholinesterase inhibitor | 0.37 0.007 CID_9395 | ||
| 0.657 | 0.007 | 0.657 | Immunosuppressant | 0.417 0.057 CID_9395 | ||
| 0.63 | 0.002 | 0.63 | Carbonic anhydrase III inhibitor | 0.135 0.035 CID_9395 | ||
| 0.524 | 0.003 | 0.524 | Carbonic anhydrase XIII inhibitor | 0.412 0.004 CID_9395 | ||
| 0.445 | 0.038 | 0.445 | Immunostimulant | 0.439 0.039 CID_9395 | ||
| 0.406 | 0.004 | 0.406 | Carbonic anhydrase VI inhibitor | |||
| 0.422 | 0.032 | 0.422 | Apoptosis antagonist | 0.233 0.144 CID_9395 | ||
| 0.379 | 0.014 | 0.379 | Platelet adhesion inhibitor | 0.214 0.064 CID_9395 | ||
| 0.353 | 0.004 | 0.353 | Autotaxin inhibitor | 0.055 0.033 CID_9395 | ||
| 0.355 | 0.007 | 0.502 | Alkaline phosphatase inhibitor | 0.502 0.004 CID_9395 | CID_9395 | |
| 0.331 | 0.003 | 0.331 | Carbonic anhydrase V inhibitor | 0.158 0.013 CID_9395 | ||
| 0.302 | 0.003 | 0.302 | Carbonic anhydrase VB inhibitor | 0.11 0.014 CID_9395 | ||
| 0.299 | 0.01 | 0.48 | UDP-glucose 4-epimerase inhibitor | 0.48 0.003 CID_9395 | CID_9395 | |
| 0.342 | 0.055 | 0.468 | Calcium channel activator | 0.468 0.008 CID_9395 | CID_9395 | |
| 0.396 | 0.113 | 0.599 | Caspase 9 stimulant | 0.599 0.036 CID_9395 | CID_9395 | |
| 0.285 | 0.003 | 0.285 | Carbonic anhydrase VA inhibitor | 0.108 0.022 CID_9395 | ||
| 0.252 | 0.004 | 0.252 | Androgen agonist | 0.095 0.017 CID_9395 | ||
| 0.249 | 0.005 | 0.249 | Sphingosine 1-phosphate receptor 4 antagonist | 0.249 0.005 CID_9395 | ||
| 0.253 | 0.031 | 0.253 | Nitric-oxide synthase stimulant | 0.253 0.031 CID_9395 | ||
| 0.221 | 0.004 | 0.221 | Carbonic anhydrase VII inhibitor | |||
| 0.22 | 0.009 | 0.508 | Triose-phosphate isomerase inhibitor | 0.508 0.002 CID_9395 | CID_9395 | |
| 0.21 | 0.008 | 0.21 | Sphingosine 1-phosphate receptor 5 antagonist | 0.209 0.008 CID_9395 | ||
| 0.262 | 0.067 | 0.262 | Superoxide dismutase inhibitor | 0.262 0.067 CID_9395 | ||
| 0.194 | 0.004 | 0.194 | Carbonic anhydrase XIV inhibitor | |||
| 0.222 | 0.034 | 0.222 | Succinate dehydrogenase inhibitor | 0.222 0.034 CID_9395 | ||
| 0.282 | 0.103 | 0.364 | Vasodilator, coronary | 0.364 0.049 CID_9395 | CID_9395 | |
| 0.317 | 0.143 | 0.317 | Calcium channel L-type activator | 0.317 0.143 CID_9395 | ||
| 0.324 | 0.156 | 0.324 | MAP kinase 1 inhibitor | |||
| 0.192 | 0.035 | 0.368 | Mannose-6-phosphate isomerase inhibitor | 0.368 0.004 CID_9395 | CID_9395 | |
| 0.166 | 0.011 | 0.166 | Carbonic anhydrase XII inhibitor | |||
| 0.172 | 0.018 | 0.218 | Calcium antagonist | 0.218 0.011 CID_9395 | CID_9395 | |
| 0.156 | 0.003 | 0.156 | Estrone sulfatase inhibitor | |||
| 0.16 | 0.014 | 0.16 | Thioredoxin inhibitor | 0.107 0.041 CID_9395 | ||
| 0.163 | 0.022 | 0.344 | Adenylate kinase inhibitor | 0.344 0.005 CID_9395 | CID_9395 | |
| 0.124 | 0.003 | 0.146 | Lysophosphatidic acid 3 receptor antagonist | 0.146 0.003 CID_9395 | CID_9395 | |
| 0.137 | 0.026 | 0.137 | Androgen antagonist | |||
| 0.127 | 0.018 | 0.127 | Purinergic P2X2 antagonist | 0.091 0.034 CID_9395 | ||
| 0.124 | 0.015 | 0.124 | Carbonic anhydrase IX inhibitor | |||
| 0.122 | 0.014 | 0.122 | Alcohol oxidase inhibitor | 0.122 0.014 CID_9395 | ||
| 0.116 | 0.012 | 0.117 | Purinergic P2X1 antagonist | 0.117 0.012 CID_9395 | CID_9395 | |
| 0.113 | 0.02 | 0.121 | Thioredoxin reductase inhibitor | 0.121 0.016 CID_9395 | CID_9395 | |
| 0.209 | 0.12 | 0.209 | Tyrosine 3 hydroxylase inhibitor | 0.209 0.12 CID_9395 | ||
| 0.119 | 0.04 | 0.268 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.268 0.008 CID_9395 | CID_9395 | |
| 0.088 | 0.009 | 0.088 | Carbonic anhydrase IV inhibitor | |||
| 0.087 | 0.013 | 0.088 | Sphingosine 1-phosphate receptor 3 antagonist | 0.088 0.012 CID_9395 | CID_9395 | |
| 0.119 | 0.046 | 0.17 | DOPA decarboxylase inhibitor | 0.17 0.013 CID_9395 | CID_9395 | |
| 0.106 | 0.033 | 0.271 | Porphobilinogen synthase inhibitor | 0.271 0.006 CID_9395 | CID_9395 | |
| 0.116 | 0.048 | 0.207 | Toll-Like receptor 4 antagonist | 0.207 0.005 CID_9395 | CID_9395 | |
| 0.102 | 0.035 | 0.254 | Glutathione S-transferase inhibitor | 0.254 0.004 CID_9395 | CID_9395 | |
| 0.234 | 0.169 | 0.234 | GABA C receptor rho-3 antagonist | 0.234 0.169 CID_9395 | ||
| 0.071 | 0.01 | 0.117 | Cholesterol esterase inhibitor | 0.117 0.004 CID_9395 | CID_9395 | |
| 0.117 | 0.057 | 0.117 | Chelator | |||
| 0.09 | 0.03 | 0.232 | Sphingosine 1-phosphate receptor 4 agonist | 0.232 0.004 CID_9395 | CID_9395 | |
| 0.109 | 0.05 | 0.131 | Creatine kinase inhibitor | 0.131 0.034 CID_9395 | CID_9395 | |
| 0.124 | 0.065 | 0.302 | Alkylator | 0.302 0.012 CID_9395 | CID_9395 | |
| 0.083 | 0.025 | 0.232 | Biliverdin reductase inhibitor | 0.232 0.004 CID_9395 | CID_9395 | |
| 0.085 | 0.033 | 0.09 | Carbonic anhydrase inhibitor | 0.09 0.03 CID_9395 | CID_9395 | |
| 0.085 | 0.039 | 0.21 | Phosphofructokinase-1 inhibitor | 0.21 0.01 CID_9395 | CID_9395 | |
| 0.09 | 0.044 | 0.127 | D-Ala-D-Ala ligase inhibitor | 0.127 0.011 CID_9395 | CID_9395 | |
| 0.084 | 0.04 | 0.228 | Histidine decarboxylase inhibitor | 0.228 0.01 CID_9395 | CID_9395 | |
| 0.053 | 0.01 | 0.089 | Glutamate (mGluR8) agonist | 0.089 0.004 CID_9395 | CID_9395 | |
| 0.179 | 0.135 | 0.372 | RNA-directed DNA polymerase inhibitor | 0.372 0.021 CID_9395 | CID_9395 | |
| 0.108 | 0.067 | 0.108 | GABA C receptor antagonist | |||
| 0.078 | 0.05 | 0.083 | Sphingosine 1-phosphate receptor antagonist | 0.083 0.039 CID_9395 | CID_9395 | |
| 0.05 | 0.025 | 0.123 | Fructose-1,6-bisphosphatase inhibitor | 0.123 0.003 CID_9395 | CID_9395 | |
| 0.038 | 0.014 | 0.054 | Lysophosphatidic acid 2 receptor antagonist | 0.054 0.008 CID_9395 | CID_9395 | |
| 0.049 | 0.026 | 0.049 | Purinergic P2X4 antagonist | 0.046 0.031 CID_9395 | ||
| 0.11 | 0.088 | 0.11 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.088 CID_9395 | ||
| 0.056 | 0.035 | 0.056 | Angiotensin-converting enzyme inhibitor | |||
| 0.092 | 0.071 | 0.117 | Aminopeptidase B inhibitor | 0.117 0.054 CID_9395 | CID_9395 | |
| 0.073 | 0.053 | 0.141 | Glutamate dehydrogenase inhibitor | 0.141 0.017 CID_9395 | CID_9395 | |
| 0.054 | 0.042 | 0.133 | Argininosuccinate synthase inhibitor | 0.133 0.013 CID_9395 | CID_9395 | |
| 0.019 | 0.007 | 0.025 | Purinergic P2Y1 agonist | 0.025 0.004 CID_9395 | CID_9395 | |
| 0.028 | 0.019 | 0.07 | Purinergic P2X agonist | 0.07 0.005 CID_9395 | CID_9395 | |
| 0.022 | 0.013 | 0.022 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.049 | 0.04 | 0.099 | Ornithine carbamoyltransferase inhibitor | 0.099 0.016 CID_9395 | CID_9395 | |
| 0.13 | 0.121 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.121 CID_9395 | ||
| 0.018 | 0.01 | 0.02 | Purinergic P2Y1 antagonist | 0.02 0.008 CID_9395 | CID_9395 | |
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 CID_9395 | ||
| 0.015 | 0.01 | 0.031 | Purinergic receptor agonist | 0.031 0.004 CID_9395 | CID_9395 | |
| 0.015 | 0.01 | 0.031 | Purinergic P2 agonist | 0.031 0.004 CID_9395 | CID_9395 | |
| 0.104 | 0.1 | 0.104 | Cathepsin H inhibitor | 0.104 0.1 CID_9395 | ||
| 0.022 | 0.019 | 0.056 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.056 0.003 CID_9395 | CID_9395 | |
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_9395 | ||
| 0.123 | 0.122 | 0.191 | Arachidonic acid antagonist | 0.191 0.041 CID_9395 | CID_9395 | |
| 0.029 | 0.029 | 0.039 | Catechol O-methyltransferase inhibitor | 0.039 0.015 CID_9395 | CID_9395 | |
| 0.011 | 0.01 | 0.023 | Purinergic P2Y agonist | 0.023 0.005 CID_9395 | CID_9395 | |
| 0.078 | 0.079 | 0.158 | NADH dehydrogenase inhibitor | 0.158 0.016 CID_9395 | CID_9395 | |
| 0.043 | 0.044 | 0.076 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 CID_9395 | CID_9395 | |
| 0.102 | 0.104 | 0.436 | Bone formation stimulant | 0.436 0.009 CID_9395 | CID_9395 | |
| 0.039 | 0.041 | 0.157 | Glutamate (mGluR group III) antagonist | 0.157 0.004 CID_9395 | CID_9395 | |
| 0.049 | 0.051 | 0.119 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.119 0.011 CID_9395 | CID_9395 | |
| 0.053 | 0.057 | 0.133 | Potassium channel intermediate-conductance Ca-activated blocker | 0.133 0.005 CID_9395 | CID_9395 | |
| 0.009 | 0.013 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 CID_9395 | CID_9395 | |
| 0.008 | 0.012 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_9395 | CID_9395 | |
| 0.189 | 0.198 | 0.218 | Calpain 2 inhibitor | 0.218 0.173 CID_9395 | CID_9395 | |
| 0.043 | 0.053 | 0.13 | Acyl-CoA dehydrogenase inhibitor | 0.13 0.011 CID_9395 | CID_9395 | |
| 0.076 | 0.088 | 0.36 | Breast cancer-resistant protein inhibitor | 0.36 0.005 CID_9395 | CID_9395 | |
| 0.018 | 0.031 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CID_9395 | CID_9395 | |
| 0.146 | 0.161 | 0.246 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.246 0.044 CID_9395 | CID_9395 | |
| 0.028 | 0.044 | 0.225 | Growth factor receptor-bound protein 2 antagonist | 0.225 0.002 CID_9395 | CID_9395 | |
| 0.026 | 0.042 | 0.107 | Purinergic P2Y2 antagonist | 0.107 0.004 CID_9395 | CID_9395 | |
| 0.018 | 0.034 | 0.043 | Uridine phosphorylase inhibitor | 0.043 0.01 CID_9395 | CID_9395 | |
| 0.079 | 0.101 | 0.127 | Anabolic | 0.127 0.033 CID_9395 | CID_9395 | |
| 0.057 | 0.079 | 0.152 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.152 0.018 CID_9395 | CID_9395 | |
| 0.041 | 0.064 | 0.076 | CDK9/cyclin T1 inhibitor | 0.076 0.028 CID_9395 | CID_9395 | |
| 0.064 | 0.092 | 0.075 | GABA B receptor agonist | 0.075 0.052 CID_9395 | CID_9395 | |
| 0.034 | 0.062 | 0.04 | Glutamate (mGluR4) antagonist | 0.04 0.038 CID_9395 | CID_9395 | |
| 0.05 | 0.08 | 0.067 | Ryanodine receptor antagonist | 0.067 0.021 CID_9395 | CID_9395 | |
| 0.083 | 0.116 | 0.117 | Amylase inhibitor | 0.117 0.083 CID_9395 | CID_9395 | |
| 0.041 | 0.074 | 0.087 | Carbamoyl phosphate synthetase inhibitor | 0.087 0.025 CID_9395 | CID_9395 | |
| 0.154 | 0.196 | 0.316 | DNA synthesis inhibitor | 0.316 0.038 CID_9395 | CID_9395 | |
| 0.018 | 0.062 | 0.038 | Fumarate hydratase inhibitor | 0.038 0.02 CID_9395 | CID_9395 | |
| 0.125 | 0.169 | 0.357 | Phospholipase C inhibitor | 0.357 0.014 CID_9395 | CID_9395 | |
| 0.023 | 0.068 | 0.044 | Purinergic P2Y antagonist | 0.044 0.032 CID_9395 | CID_9395 | |
| 0.038 | 0.087 | 0.092 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.092 0.019 CID_9395 | CID_9395 | |
| 0.012 | 0.067 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 CID_9395 | CID_9395 | |
| 0.023 | 0.077 | 0.035 | Glutamate (mGluR4) agonist | 0.035 0.021 CID_9395 | CID_9395 | |
| 0.108 | 0.164 | 0.164 | Melanin inhibitor | 0.164 0.065 CID_9395 | CID_9395 | |
| 0.03 | 0.089 | 0.048 | Collagenase inhibitor | 0.048 0.038 CID_9395 | CID_9395 | |
| 0.002 | 0.061 | 0.022 | Mannitol 2-dehydrogenase inhibitor | 0.022 0.002 CID_9395 | CID_9395 | |
| 0.066 | 0.125 | 0.112 | Cyclin-dependent kinase 9 inhibitor | 0.112 0.051 CID_9395 | CID_9395 | |
| 0.026 | 0.087 | 0.042 | Adenosine uptake inhibitor | 0.042 0.009 CID_9395 | CID_9395 | |
| 0.149 | 0.213 | 0.49 | Transcription factor STAT3 inhibitor | 0.49 0.007 CID_9395 | CID_9395 | |
| 0.05 | 0.115 | 0.085 | Glutamate (mGluR6) antagonist | 0.085 0.02 CID_9395 | CID_9395 | |
| 0.036 | 0.102 | 0.063 | Sodium/calcium exchanger inhibitor | 0.063 0.017 CID_9395 | CID_9395 | |
| 0.018 | 0.086 | 0.044 | Urokinase inhibitor | 0.044 0.036 CID_9395 | CID_9395 | |
| 0.058 | 0.129 | 0.134 | Alcohol dehydrogenase inhibitor | 0.134 0.027 CID_9395 | CID_9395 | |
| 0.036 | 0.106 | 0.057 | Nitric oxide donor | 0.057 0.054 CID_9395 | CID_9395 | |
| 0.077 | 0.151 | 0.169 | Cyclooxygenase 3 inhibitor | 0.169 0.034 CID_9395 | CID_9395 | |
| 0.015 | 0.094 | 0.041 | TRPM8 blocker | 0.041 0.023 CID_9395 | CID_9395 | |
| 0.089 | 0.169 | 0.302 | Phospholipase A2 inhibitor | 0.302 0.013 CID_9395 | CID_9395 | |
| 0.042 | 0.122 | 0.089 | Bcl2 antagonist | 0.089 0.025 CID_9395 | CID_9395 | |
| 0.014 | 0.095 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 CID_9395 | CID_9395 | |
| 0.02 | 0.104 | 0.065 | Oleamide hydrolase inhibitor | 0.065 0.018 CID_9395 | CID_9395 | |
| 0.083 | 0.175 | 0.181 | Transcription factor STAT6 inhibitor | 0.181 0.01 CID_9395 | CID_9395 | |
| 0.092 | 0.186 | 0.181 | Sphingosine 1-phosphate receptor 2 antagonist | 0.181 0.014 CID_9395 | CID_9395 | |
| 0.021 | 0.116 | 0.073 | Leukocyte elastase inhibitor | 0.073 0.014 CID_9395 | CID_9395 | |
| 0.062 | 0.158 | 0.089 | Xanthine oxidase inhibitor | 0.089 0.074 CID_9395 | CID_9395 | |
| 0.123 | 0.22 | 0.276 | DNA damaging | 0.276 0.068 CID_9395 | CID_9395 | |
| 0.023 | 0.122 | 0.042 | AICAR transformylase inhibitor | 0.042 0.034 CID_9395 | CID_9395 | |
| 0.012 | 0.111 | 0.042 | Phosphoglycerate kinase inhibitor | 0.042 0.018 CID_9395 | CID_9395 | |
| 0.023 | 0.126 | 0.038 | Glutamate (mGluR group III) agonist | 0.038 0.037 CID_9395 | CID_9395 | |
| 0.057 | 0.164 | 0.097 | Transcription factor NF kappa B stimulant | 0.097 0.042 CID_9395 | CID_9395 | |
| 0.057 | 0.166 | 0.156 | DNA directed RNA polymerase inhibitor | 0.156 0.022 CID_9395 | CID_9395 | |
| 0.015 | 0.13 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | 0.061 0.034 CID_9395 | CID_9395 | |
| 0.068 | 0.186 | 0.132 | TRPA1 agonist | 0.132 0.046 CID_9395 | CID_9395 | |
| 0.014 | 0.132 | 0.063 | Ribonucleotide reductase inhibitor | 0.063 0.034 CID_9395 | CID_9395 | |
| 0.045 | 0.165 | 0.081 | Keratolytic | 0.081 0.047 CID_9395 | CID_9395 | |
| 0.075 | 0.197 | 0.168 | Protein kinase stimulant | 0.168 0.056 CID_9395 | CID_9395 | |
| 0.138 | 0.263 | 0.262 | Vasodilator, peripheral | 0.262 0.118 CID_9395 | CID_9395 | |
| 0.095 | 0.221 | 0.233 | Interleukin agonist | 0.233 0.092 CID_9395 | CID_9395 | |
| 0.038 | 0.164 | 0.216 | Potassium channel (Ca-activated) activator | 0.216 0.012 CID_9395 | CID_9395 | |
| 0.017 | 0.146 | 0.055 | Thymidylate synthase inhibitor | 0.055 0.022 CID_9395 | CID_9395 | |
| 0.013 | 0.148 | 0.063 | Antimetabolite | 0.063 0.024 CID_9395 | CID_9395 | |
| 0.045 | 0.182 | 0.135 | Sphingomyelinase inhibitor | 0.135 0.032 CID_9395 | CID_9395 | |
| 0.084 | 0.225 | 0.158 | Vanilloid 1 agonist | 0.158 0.031 CID_9395 | CID_9395 | |
| 0.086 | 0.232 | 0.149 | Adenylate cyclase stimulant | 0.149 0.064 CID_9395 | CID_9395 | |
| 0.01 | 0.162 | 0.056 | Carbonic anhydrase I inhibitor | 0.056 0.038 CID_9395 | CID_9395 | |
| 0.122 | 0.276 | 0.251 | Cholesterol antagonist | 0.251 0.124 CID_9395 | CID_9395 | |
| 0.02 | 0.176 | 0.039 | Thymidine kinase inhibitor | 0.039 0.031 CID_9395 | CID_9395 | |
| 0.111 | 0.273 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.066 CID_9395 | CID_9395 | |
| 0.01 | 0.174 | 0.055 | Carbonic anhydrase II inhibitor | 0.055 0.039 CID_9395 | CID_9395 | |
| 0.125 | 0.291 | 0.504 | Transcription factor STAT inhibitor | 0.504 0.008 CID_9395 | CID_9395 | |
| 0.056 | 0.227 | 0.082 | 3C-Like protease (SARS coronavirus) inhibitor | 0.082 0.064 CID_9395 | CID_9395 | |
| 0.066 | 0.243 | 0.303 | Pyruvate kinase inhibitor | 0.303 0.047 CID_9395 | CID_9395 | |
| 0.09 | 0.267 | 0.571 | Vasodilator | 0.571 0.007 CID_9395 | CID_9395 | |
| 0.072 | 0.251 | 0.201 | Hexokinase inhibitor | 0.201 0.035 CID_9395 | CID_9395 | |
| 0.04 | 0.228 | 0.15 | Cholesterol synthesis inhibitor | 0.15 0.044 CID_9395 | CID_9395 | |
| 0.076 | 0.264 | 0.142 | DNA repair enzyme inhibitor | 0.142 0.039 CID_9395 | CID_9395 | |
| 0.051 | 0.244 | 0.145 | Cytidine deaminase inhibitor | 0.145 0.079 CID_9395 | CID_9395 | |
| 0.053 | 0.262 | 0.139 | Toll-Like receptor 2 antagonist | 0.139 0.061 CID_9395 | CID_9395 | |
| 0.073 | 0.301 | 0.338 | Non-steroidal antiinflammatory agent | 0.338 0.021 CID_9395 | CID_9395 | |
| 0.086 | 0.317 | 0.194 | Cyclic AMP phosphodiesterase inhibitor | 0.194 0.098 CID_9395 | CID_9395 | |
| 0.093 | 0.339 | 0.263 | Catenin beta inhibitor | 0.263 0.009 CID_9395 | CID_9395 | |
| 0.028 | 0.295 | 0.138 | Potassium channel large-conductance Ca-activated activator | 0.138 0.013 CID_9395 | CID_9395 | |
| 0.099 | 0.371 | 0.338 | Transcription factor inhibitor | 0.338 0.136 CID_9395 | CID_9395 | |
| 0.048 | 0.33 | 0.141 | Cell wall synthesis inhibitor | 0.141 0.074 CID_9395 | CID_9395 | |
| 0.039 | 0.35 | 0.168 | Toll-Like receptor antagonist | 0.168 0.044 CID_9395 | CID_9395 | |
| 0.042 | 0.375 | 0.09 | Glutamate (mGluR7) agonist | 0.09 0.084 CID_9395 | CID_9395 | |
| 0.056 | 0.392 | 0.158 | Antioxidant | 0.158 0.155 CID_9395 | CID_9395 | |
| 0.049 | 0.397 | 0.137 | DNA methylase inhibitor | 0.137 0.13 CID_9395 | CID_9395 | |
| 0.076 | 0.46 | 0.289 | Antibacterial | 0.289 0.144 CID_9395 | CID_9395 | |
| 0.02 | 0.41 | 0.053 | Antiviral (Hepatitis D) | 0.053 0.031 CID_9395 | CID_9395 | |
| 0.053 | 0.452 | 0.403 | DNA directed DNA polymerase inhibitor | 0.403 0.114 CID_9395 | CID_9395 | |
| 0.042 | 0.443 | 0.095 | Interleukin 12 antagonist | 0.095 0.063 CID_9395 | CID_9395 | |
| 0.047 | 0.457 | 0.234 | DNA polymerase beta inhibitor | 0.234 0.202 CID_9395 | CID_9395 | |
| 0.019 | 0.431 | 0.091 | DNA intercalator | 0.091 0.084 CID_9395 | CID_9395 | |
| 0.029 | 0.476 | 0.189 | DNA polymerase I inhibitor | 0.189 0.032 CID_9395 | CID_9395 | |
| 0.052 | 0.508 | 0.271 | Antithrombotic | 0.271 0.11 CID_9395 | CID_9395 | |
| 0.016 | 0.473 | 0.165 | Psychostimulant | 0.165 0.104 CID_9395 | CID_9395 | |
| 0.027 | 0.514 | 0.204 | Platelet antagonist | 0.204 0.098 CID_9395 | CID_9395 | |
| 0.011 | 0.522 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.007 CID_9395 | CID_9395 | |
| 0.008 | 0.535 | 0.073 | ZAP-70 protein tyrosine kinase inhibitor | 0.073 0.044 CID_9395 | CID_9395 | |
| 0.01 | 0.544 | 0.299 | Tubulin antagonist | 0.299 0.019 CID_9395 | CID_9395 | |
| 0.013 | 0.61 | 0.131 | Lipid peroxidase inhibitor | 0.131 0.083 CID_9395 | CID_9395 | |
| 0.005 | 0.627 | 0.195 | c-Src kinase inhibitor | 0.195 0.037 CID_9395 | CID_9395 | |
| 0.003 | 0.646 | 0.126 | Sphingosine 1-phosphate receptor 3 agonist | 0.126 0.005 CID_9395 | CID_9395 | |
| 0.04 | 0.687 | 0.639 | Apoptosis agonist | 0.639 0.041 CID_9395 | CID_9395 | |
| 0.014 | 0.704 | 0.157 | Antiamyloidogenic | 0.157 0.138 CID_9395 | CID_9395 | |
| 0.016 | 0.718 | 0.206 | Amyloid beta aggregation inhibitor | 0.206 0.075 CID_9395 | CID_9395 | |
| 0.009 | 0.716 | 0.078 | Potassium channel (Ca-activated) blocker | 0.078 0.019 CID_9395 | CID_9395 | |
| 0.012 | 0.73 | 0.415 | Platelet aggregation inhibitor | 0.415 0.017 CID_9395 | CID_9395 | |
| 0.005 | 0.808 | 0.145 | Src kinase inhibitor | 0.145 0.086 CID_9395 | CID_9395 | |
| 0.036 | 0.856 | 0.206 | Sphingosine 1-phosphate receptor 2 agonist | 0.206 0.01 CID_9395 | CID_9395 | |
| 0.004 | 0.857 | 0.123 | Platelet activating factor antagonist | 0.123 0.061 CID_9395 | CID_9395 | |
| 0.005 | 0.889 | 0.087 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.064 CID_9395 | CID_9395 | |
| 0.004 | 0.953 | 0.059 | Sphingosine 1-phosphate receptor 5 agonist | 0.059 0.027 CID_9395 | CID_9395 | |
| 0.004 | 0.984 | 0.366 | Antimitotic | 0.366 0.029 CID_9395 | CID_9395 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |